Description
IGF::CT::IGF - BIOMERIEUX VITEK SHALL TROUBLESHOOT AND SUPPLY ANY NEEDED REPAIR PARTS FOR THE REPAIR OF THE VITEK2 ANALYZER. THE VITEK2 ANALYZER IS CURRENTLY RECEIVING PIPETTE ERRORS AND THE CONTRACTOR IS EXPECTED TO BRING EQUIPMENT BACK UP TO FULL OPERATION STATUS PER MANUFACTURER S SPECIFICATIONS. FULL FACTORY PREVENTATIVE MAINTENANCE SHALL ALSO BE COMPLETED ON THE VITEK2 PER MANUFACTURER S SPECIFICATIONS.
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2014-02-27+$6,078= $6,078
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2014-02-27 | +$6,078 | $6,078 | IGF::CT::IGF - BIOMERIEUX VITEK SHALL TROUBLESHOOT AND SUPPLY ANY NEEDED REPAIR PARTS FOR THE REPAIR OF THE VI… |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI HCNVCMEG9NL6)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25926F0276 | NETWORK CONTRACT OFFICE 19 (36C259) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES | $60,940 | FY2026 |
| 36C25726N0441 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6632 · ANALYSIS INSTRUMENTS, MEDICAL LABORATORY USE | $122,631 | FY2026 |
| 36C25726D0091 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6632 · ANALYSIS INSTRUMENTS, MEDICAL LABORATORY USE | $0 | FY2026 |
| 36C26226N0903 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $67,946 | FY2026 |
| 36C24926N0666 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $982,841 | FY2026 |
| 36C24126N0842 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $310,739 | FY2026 |
Other recipients under Q301 from 552-DAYTON (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA25016P0488 | ATHENA DIAGNOSTICS, INC | 552-DAYTON | $9,999 | FY2016 |
| VA25013P1020 | MYRIAD GENETIC LABORATORIES INC | 552-DAYTON | $6,764 | FY2013 |
| VA25013F0126 | GOVERNMENT SCIENTIFIC SOURCE INC | 552-DAYTON | $36,480 | FY2013 |
| VA25012F0499 | POLYMEDCO LLC | 552-DAYTON | $28,980 | FY2012 |
| VA25012F0125 | SIEMENS HEALTHCARE DIAGNOSTICS INC. | 552-DAYTON | $144,211 | FY2012 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA25014F1316_3600_V797P7128A_3600 · retrieved 2026-09-26.